FDA Approves Cholera Vaccine for U.S. Travelers

Share this content:
FDA Approves Cholera Vaccine for U.S. Travelers
FDA Approves Cholera Vaccine for U.S. Travelers

MONDAY, June 13, 2016 (HealthDay News) -- The first vaccine to protect American travelers from cholera has been approved by the U.S. Food and Drug Administration.

The liquid vaccine Vaxchora was approved for adults ages 18 to 64 who are traveling to countries affected by cholera, the Associated Press reported.

The FDA's approval of the vaccine is based on four clinical trials that included a total of 3,797 people. Ninety-three and 90 percent of participants produced antibodies indicative of protection against cholera in the 18 through 45 and 46 through 64 age groups, respectively. Common side effects included abdominal pain, diarrhea, headache, and fatigue, the AP reported.

"The approval of Vaxchora represents a significant addition to the cholera-prevention measures currently recommended by the U.S. Centers for Disease Control and Prevention for travelers to cholera-affected regions," Peter Marks, M.D., Ph.D., director of the FDA's Center for Biologics Evaluation and Research, said in a statement.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ground Beef Recalled After E. Coli Outbreak

Ground Beef Recalled After <i>E. Coli</i> Outbreak

Beef was produced and packaged at Cargill Meat Solutions in Fort Morgan, Colo.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060

Long-Term Outcomes of Breast Implants Explored

Long-Term Outcomes of Breast Implants Explored

Higher rates of Sjogren syndrome, scleroderma, RA, stillbirth, melanoma for silicone implants

is free, fast, and customized just for you!




Already a member?

Sign In Now »